---
$id: https://graph.org.ai/products/commodity/51111744
$type: Product
source: UNSPSC
code: "51111744"
title: "Galarubicin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Galarubicin

**UNSPSC Code**: 51111744
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic with the molecular formula C30H32FNO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6F39648E92, chemically known as (8s,10s)-10-((2.6-dideoxy-2-fluoro-alpha-l-talopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione 8(2)-ester with beta-alanine. but generally known as galarubicin, which bears US NIH Compound Identifier 219086. European Medicines Agency schedules Galarubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02302MIG. The term GALARUBICIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule galarubicin under HS 29419000 and SITC 54139. As of Q4 2014, GALARUBICIN remains the US FDA Preferred Term for this commodity. Galarubicin bears US NLM identifiers UMLS ID C2825624 and NCI Concept Code C81422. SMILES: FC1C(OC2CC(O)(CC3C2C(O)C2C(C3O)C(=O)C3C(C2=O)C(OC)CCC3)C(=O)COC(=O)CCN)OC(C(O)C1O)C.

